Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07505004 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures

Name: Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures — clinical trial record (NCT07505004)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: POWER2

StatusActive, Not Recruiting

PhasePhase 3

SponsorPraxis Precision Medicines

Started2026-01-29

View on ClinicalTrials.gov ↗

Amendment history

2026-07-31

Study Identification, Study Status, Outcome Measures, Contacts/Locations v1

Enrollment closed, study ongoing

Secondary endpointsdetails revised at 1 of 10 entries

Study sitesdetails revised at 7 of 7 sites

Study title-14 characters

~~Double-blind,~~ Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures

2026-03-26

Original filing

Praxis Precision Medicines

10 trials monitored

See 2 trials at risk

Epilepsy

723 trials monitored

See 41 trials at risk

A multicenter, double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of vormatrigine in adults with focal seizures (POWER2)

Trial Details

NCT Number	NCT07505004
Lead Sponsor	Praxis Precision Medicines
Conditions	Focal Epilepsy
Enrollment	300 participants
Start Date	2026-01-29
Primary Completion	2027-01 (estimated)
Study Completion	2027-05 (estimated)
Updated on ClinicalTrials.gov	2026-08-03